Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2024 07:00 ET | Source: Oxford BioMedica plc

Oxford Biomedica – Half Year Trading Update and Notice of Interim Results

Half Year Trading Update and Notice of Interim Results Full year 2024 revenue and medium-term financial guidance reiterated; underpinned by OXB’s growing market share in the expanding cell and gene...
September 07, 2023 07:00 ET | Source: Oxford BioMedica plc

Oxford Biomedica to host webinar showcasing the TetraVecta™ system

Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led...
September 14, 2022 07:00 ET | Source: Oxford Biomedica Solutions LLC

Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs

Oxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programs Bedford, Massachusetts – September 14, 2022: Oxford Biomedica Solutions LLC, an Oxford...
March 11, 2022 07:00 ET | Source: Oxford BioMedica plc

Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology

Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customers Oxford, UK – 11 March 2022: Oxford Biomedica plc...